Search In this Thesis
   Search In this Thesis  
العنوان
Study of the relation between serum levels of long acting penicillin and the inflammatory markers: C-Reactive Protein and Interleukin-6 in patients with chronic rheumatic heart disease /
المؤلف
Mohammad,Ahmad Mahmoud Yousef.
هيئة الاعداد
باحث / Ahmad Mahmoud Yousef Mohammad
مشرف / Osama Abdel Aziz Rifaie
مشرف / Mohamed Atef Hamza
مشرف / Sameh Attia Amin
تاريخ النشر
2019
عدد الصفحات
84p.:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض القلب والطب القلب والأوعية الدموية
تاريخ الإجازة
1/1/2019
مكان الإجازة
جامعة عين شمس - كلية الطب - لقلب والأوعية الدمومة
الفهرس
Only 14 pages are availabe for public view

from 84

from 84

Abstract

Rheumatic fever is a delayed immunologically mediated autoimmune sequela of throat infection by group A β-hemolytic streptococci, and it is a multisystem inflammatory disease that can affect different tissues including synovial joints and cardiac valves.
The current hypothesis of chronic rheumatic heart disease is that following acute RF attack, there will be a continuous chronic inflammation of cardiac valves and patients with more intense inflammatory reaction have a more rapid progression of valvular dysfunction.
The Aim of the work was to study the relation between serum levels of long acting penicillin and the inflammatory markers C - reactive protein and Interleukin-6 in patients with chronic rheumatic heart disease. And this would help to detect the real efficacy of long acting penicillin in secondary prevention of rheumatic heart disease.
Eighty patients from rheumatic heart disease patients coming to Ain Shams university hospitals’ outpatient clinic for rheumatic fever prophylaxis by regular long acting penicillin administration were subjected to the study. Patients were divided into to 2 groups: group A ; 70 patients with rheumatic heart disease already on long acting penicillin ,and group B ;10 patients with rheumatic heart disease who have not started long acting penicillin yet in addition to group C ; control group of
10 healthy individuals not known to have rheumatic heart disease and long acting penicillin has a strong effect in secondary prevention of chronic rheumatic heart disease and its inflammatory mediators.